Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07533136 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is to conduct a clinical trial of tafenoquine combinations to compare the rates of therapeutic efficacy of dihydroartemisinin-piperaquine or artemether-lumefantrine with tafenoquine to chloroquine plus tafenoquine in preventing recurrence of Plasmodium vivax over a 6-month period in adult subjects with uncomplicated P. vivax infection living in Thailand.
Trial Details
NCT Number NCT07533136
Lead Sponsor Walter Reed Army Institute of Research (WRAIR)
Conditions
(from sponsor)		 Uncomplicated P. Vivax Mono-infection
Related terms Malaria, Vivax
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov